Medical and Science
RACGP warns of higher costs for patients needing ECGs

Medical News: The Royal Australian College of General Practitioners (RACGP) is warning that patients who need electrocardiograms (ECGs) will likely face higher costs due to imminent changes to the Medicare Benefits Schedule (MBS).
The changes to MBS items for ECGs, due to come into force on August 1st, will significantly reduce patient rebates for ECGs in general practice, effectively restricting these services to consultant physicians and other specialists.
Under the changes, patients will only be eligible for item 11707 for ECG tracing in general practice, and will no longer be able to claim for tracing and reporting. This will result in a substantially lowered patient rebate.
RACGP President Dr Harry Nespolon said the changes would likely result in higher costs and inconvenience for patients.
“The RACGP is deeply disappointed at the decision to reduce patient rebates for ECGs in general practice – these changes are likely to hurt patients through higher costs and inconvenience.
“The decision completely fails to recognise the work GPs do with ECGs – we perform interpretation, report results in patient records and determine actions that need to be taken, very often without needing to refer patients to another specialist for interpretation and reporting.
“The changes mean patients will more likely have to go to more expensive specialists for these services and face higher out of pocket costs.
“The RACGP advocated strongly against these changes for good reason. Chronic conditions requiring ECGs and associated care like heart problems are increasing in Australia.
“Primary care is the most cost effective way of providing high-quality care for such patients – the government should be investing in primary care to keep patients out of the hospital system, instead we are seeing this ripped away.”
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More